Prediction: New Reason Lilly Stock Could Still Rise
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Identify dividend ETFs with competitive fees and solid value. Learn key criteria and compare options to optimize your costs today.
27,814 articlesEli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Oil-driven moves lift lucid (lcid) rivian (rivn) shares, while tesla (tsla) faces regulatory scrutiny and BYD competi...
OpenAI’s growing power needs are drawing attention to a little-known Michigan utility tied to a major data-center dea...
Meta Platforms expands its lead in scalable ads and AI infrastructure, widening the gap to Palantir, whose high multi...
IBM stock slides as Anthropic's AI code tool threatens IBM's COBOL modernization business, forcing investors to repri...
Texas Instruments is outperforming NVIDIA in 2026 as the chip landscape shifts from GPU hype to broad AI infrastructu...
Analysts model a five-year horizon for Broadcom, showing a pathway where a $5,000 stake could grow significantly by 2...
The AI boom has drawn big names into the stock market arena. This article breaks down what billionaire Stanley Drucke...
Crispr Therapeutics Stock Absurdly Cheap signals a rare biotech bargain. Learn what could drive a 437% upside, the ca...
Investors have watched robinhood stock been volatile as the company transitions from breakneck growth to a steadier, ...
Cerebras just pulled biggest IPO momentum sent shockwaves through tech stocks. This article breaks down what that imp...
Three long-time CBS News correspondents pledged to stay with the program amid a leadership shake-up, signaling a deli...